Talk:Samuel Dagogo-Jack
Add topic | This page was proposed for deletion by an editor in the past. |
| This article must adhere to the biographies of living persons (BLP) policy, even if it is not a biography, because it contains material about living persons. Contentious material about living persons that is unsourced or poorly sourced must be removed immediately from the article and its talk page, especially if potentially libellous. If such material is repeatedly inserted, or if you have other concerns, please report the issue to this noticeboard.If you are a subject of this article, or acting on behalf of one, and you need help, please see this help page. |
 | This article is rated Start-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | ||||||||||
| |||||||||||
http://www.uthsc.edu/endocrinology/chiefs-message.php — Preceding unsigned comment added by 72.196.101.79 (talk) 23:02, 6 June 2013 (UTC)
Objective notability
[edit]I noticed that he wrote a detailed article about a giant in Endocrinology, Philip E. Cryer. To be chosen to do so by the American Diabetes Association suggests a high level of prominence within the field. After a deeper review of reliable sources, there appears to be strong evidence that Samuel E. Dagogo-Jack, MD, DSc clearly meets Wikipedia’s notability guidelines for medical academics.
He is the A.C. Mullins Endowed Professor of Medicine and Chief of the Division of Endocrinology, Diabetes, and Metabolism at the University of Tennessee Health Science Center, where he directs major clinical-research programs and fellowship training. He is a leading figure in diabetes research, having authored more than 500 peer-reviewed publications, with over '''29,000 citations''' and an '''h-index of approximately 66'''. He has served as principal investigator on major NIH-funded studies including the Diabetes Prevention Program (DPP/DPPOS), DCCT/EDIC, and the POP-ABC study. His research has contributed significantly to scientific understanding of prediabetes, metabolic risk, leptin biology, glucose counterregulation, and diabetes prevention.
Further demonstrating his prominence, Dagogo-Jack served as President (Medicine & Science) of the American Diabetes Association and has received several major honors, including the ADA’s 2024 Outstanding Achievement in Clinical Diabetes Research Award and the Banting Medal for Leadership. Taken together, his extensive scholarly impact, leadership positions, and sustained contributions to clinical outcomes research support expanding the article beyond its current Start-class status and clearly satisfy notability requirements for a biography of a medical professional. RPK2000 (talk) 21:45, 7 December 2025 (UTC)